Institutional investors purchased a net $1.4 million shares of GHDX during the quarter ended June 2015, and now own 93.56% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD OVERSEAS LTD. Bought 4.3 Thousand shares of Genomic Health Inc
CREDIT SUISSE AG Bought 500.00 shares of Genomic Health Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 107.00 shares of Genomic Health Inc